Evidence map›Paper›PMID 40641143›Full record

ReviewOncology reports2025

Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (Review).

Yun-Fan Li, Shuai Su, Yu Luo, Chengcheng Wei, Jingke He, Liang-Dong Song, Kun Han, Jue Wang, Xiangzhi Gan, De-Lin Wang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yun-Fan LiDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Shuai SuDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Yu LuoDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Chengcheng WeiDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Jingke HeDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Liang-Dong SongDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Kun HanDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Jue WangDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Xiangzhi GanDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
De-Lin WangDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroendocrine (NE) prostate cancer (NEPC) is an aggressive and lethal subtype of prostate cancer. It is typically characterized by the expression of NE markers and the loss of androgen receptor expression.

Indexed as

Epithelial-Mesenchymal TransitionNeoplastic Stem CellsProstatic NeoplasmsCell DifferentiationDrug Resistance, NeoplasmHumansMaleepithelial‑mesenchymal transitionmolecular mechanism androgen signalingneuroendocrine prostate cancerstemness

Identifiers

PMID40641143
PMCPMC12271840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.